Subsequently, two upregulated diagnostic biomarkers, ADD3 and GNAS, were confirmed using the validation cohort, which, like the metadata cohort, included up to six datasets, demonstrating robust expression patterns consistent with their proposed roles in COPD. This evidence concerns the gene ADD3 and chronic obstructive pulmonary disease.